Skip to main content
Original Research, Adverse Events, Transplant
Evaluation of Treatment With Eltrombopag in Patients With Posttransplant Thrombocytopenia
Sarah Blocker, PharmD; Maggie Nelson, PharmD, BCOP; Zahra Mahmoudjafari, PharmD, MBA, BCOP; Vincent Cascone, PharmD, BCOP; Dennis Grauer, MS, PhD; Denae Beckman, PharmD, BCOP
Read More
Review Article, Adverse Events, Multiple Myeloma, Practical Issues in Pharmacy Management
BCMA-Directed Bispecific Antibodies for Multiple Myeloma: Practical Approaches to Patient Management
Charlotte B. Wagner, PharmD, BCOP; Mary Steinbach, DNP, APRN; Dennis Verducci, MSN, RN, NP-BC, OCN; Andrew Kowalski, PharmD, BCOP
Read More
Case Reports, Pediatric Cancer, Leukemia, Adverse Events
Calaspargase-Pegol Use in a Pediatric Patient Receiving Continuous Renal Replacement Therapy: Case Report
Savannah Mace, PharmD; Mansi Dalal, MD; Emilie J. Lynch, PharmD
Read More
Case Reports, Myelofibrosis, Dose Escalation/Reduction
Pacritinib Therapy in a Patient With End-Stage Renal Disease in the Setting of Cytopenic Myelofibrosis
Alexandra Roach, MD; Hayley Heers, PharmD, BCPS, BCOP; Vishangi Dave, MD; Naveen Pemmaraju, MD; Matthew Ulrickson, MD
Read More
Online First
Original Research, Adverse Events, Multiple Myeloma, Immunotherapy, Thromboembolism
Assessment of Appropriate Anticoagulation in Patients With Multiple Myeloma—A Health-System Specialty Pharmacy Retrospective Evaluation
Addie Planas, PharmD, CSP, CPh; Brittany Alvarez, PharmD, MBA; Beatriz Jimenez Cadilla, PharmD, BCACP; Karina Delgado, PharmD, MBA, BCPS; Jacqualine Igwe, PharmD, BCPS, et al.
Read More
Online First
HOPA Corner
Don’t Stop Believing—Putting the Person Back Into Practice
Robert Mancini, PharmD, BCOP, FHOPA
Read More
HOPA Corner, Immunotherapy
Advancing Merkel-Cell Carcinoma Treatment With Immunotherapy
Read More
Voices From ASCO 2025
Advancing Treatments for Prostate and Bladder Cancers and Ensuring Equitable Access to Care: An Interview with Dr. Walter Stadler
Read More
Online First
Original Research, Thromboembolism, Gastrointestinal Cancers
Evaluation of Bleeding Risk With Apixaban Versus Rivaroxaban in Patients With Gastrointestinal Cancer
Parker Gundersen, PharmD, MBA, BCOP; Alexa Basilio, PharmD, BCOP; Amber Draper, PharmD, BCOP; Marley Watson, PharmD, BCOP; Emily Tiao, PharmD, BCOP, et al.
Read More
Online First
Case Reports, Adverse Events, Immunotherapy, Infusion Issues, Monoclonal Antibodies
Management of Severe Hypersensitivity Reaction and Serum Sickness in a Case of Aplastic Anemia: Case Report Using Tocilizumab
David C. Sabatino, PharmD, BCOP; Alina Varabyeva, PharmD, BCOP; Joseph Jurcic, MD
Read More
Page 11 of 199
Results 101 - 110 of 1986